Evaluation of two screening methods for undiagnosed diabetes in China: an cost-effectiveness study
- PMID: 24021478
- DOI: 10.1016/j.pcd.2013.08.003
Evaluation of two screening methods for undiagnosed diabetes in China: an cost-effectiveness study
Abstract
Aims: To evaluate the performance and cost-effectiveness of two screening methods to identify undiagnosed diabetes at primary care settings among a Chinese population.
Methods: Two screening methods using a fasting capillary glucose (FCG) test or a Chinese diabetes risk score (DRS) at primary care settings followed by diagnostic tests were compared. The performance of FCG and DRS was evaluated by using receiver operating characteristic (ROC) curve analysis. The main economic outcome measures were the total cost of screening per 1000 persons, proportion of undiagnosed diabetes detected, and cost per undiagnosed diabetes identified from the societal perspective.
Results: Among all participants, 14.6% (1349/9232) had undiagnosed diabetes defined by fasting plasma glucose ≥ 7.0mmol/l and/or 2h plasma glucose ≥ 11.1mmol/l and/or hemoglobin A1c ≥ 6.5%. At the optimal cutoff point of 6.1mmol/l for FCG and 14 for DRS, the sensitivity was 65.1% and 65.8%, and specificity was 72.4% and 55.2%, respectively. The area under the ROC curve was 75.3% for FCG and 63.7% for DRS (P<0.001). Based on the input costs, the total cost of screening 1000 persons was ¥64,000 ($9143) for FCG and ¥81,000 ($11,571) for DRS. The average cost per case identified was ¥674 ($96) for FCG at cutoff point of 6.1mmol/l and ¥844 ($121) for DRS at score of 14. The incremental cost per case identified was ¥17,000 ($2429) for DRS compared to FCG. The dominance relations between strategies remained with the changed in sensitivity analysis.
Conclusions: As a first-line screening tool for undiagnosed diabetes, the FCG test performed better than the DRS in primary care settings in China. The non-invasive and layperson-oriented DRS was feasible and detected more cases but more expensive. No strategy has strong dominance that was both more effective and less costly. The favorable strategy will depend on if the purpose of the screening program is to identify more cases or to have lower cost per case.
Keywords: Cost; Diabetes risk score; Fasting capillary glucose; Screening; Type 2 diabetes.
Copyright © 2013 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Point-of-care Testing HbA1c screening for type 2 diabetes in urban and rural areas of China: a cost-effectiveness analysis.Front Public Health. 2024 Jul 30;12:1438945. doi: 10.3389/fpubh.2024.1438945. eCollection 2024. Front Public Health. 2024. PMID: 39139662 Free PMC article.
-
Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao, China.Diabetes Care. 2010 Mar;33(3):545-50. doi: 10.2337/dc09-1410. Epub 2009 Dec 10. Diabetes Care. 2010. PMID: 20007941 Free PMC article.
-
Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.Acta Diabetol. 2010 Sep;47(3):231-6. doi: 10.1007/s00592-009-0143-2. Epub 2009 Sep 17. Acta Diabetol. 2010. PMID: 19760291
-
Screening for type 2 diabetes: literature review and economic modelling.Health Technol Assess. 2007 May;11(17):iii-iv, ix-xi, 1-125. doi: 10.3310/hta11170. Health Technol Assess. 2007. PMID: 17462167 Review.
-
Use of high-normal levels of haemoglobin A(1C) and fasting plasma glucose for diabetes screening and for prediction: a meta-analysis.Diabetes Metab Res Rev. 2013 Nov;29(8):680-92. doi: 10.1002/dmrr.2445. Diabetes Metab Res Rev. 2013. PMID: 23963843 Review.
Cited by
-
Point-of-care Testing HbA1c screening for type 2 diabetes in urban and rural areas of China: a cost-effectiveness analysis.Front Public Health. 2024 Jul 30;12:1438945. doi: 10.3389/fpubh.2024.1438945. eCollection 2024. Front Public Health. 2024. PMID: 39139662 Free PMC article.
-
Cost-effectiveness of two screening strategies based on Chinese diabetes risk score for pre-diabetes in China.Front Public Health. 2022 Nov 30;10:1018084. doi: 10.3389/fpubh.2022.1018084. eCollection 2022. Front Public Health. 2022. PMID: 36530668 Free PMC article.
-
Predictors of Undiagnosed Diabetes among Middle-Aged and Seniors in China: Application of Andersen's Behavioral Model.Int J Environ Res Public Health. 2021 Aug 8;18(16):8396. doi: 10.3390/ijerph18168396. Int J Environ Res Public Health. 2021. PMID: 34444146 Free PMC article.
-
Quality of Health Economic Evaluations in Mainland China: A Comparison of Peer-Reviewed Articles in Chinese and in English.Appl Health Econ Health Policy. 2022 Jan;20(1):35-54. doi: 10.1007/s40258-021-00674-0. Epub 2021 Jul 29. Appl Health Econ Health Policy. 2022. PMID: 34322862
-
Performance and costs of multiple screening strategies for type 2 diabetes: two population-based studies in Shanghai, China.BMJ Open Diabetes Res Care. 2020 Aug;8(1):e001569. doi: 10.1136/bmjdrc-2020-001569. BMJ Open Diabetes Res Care. 2020. PMID: 32816870 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials